Ocular Surface Disease

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Ocular Surface Disease is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

20/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed4 · 40%

Unknown status2 · 20%

Withdrawn2 · 20%

Recruiting1 · 10%

Not yet recruiting1 · 10%

Clinical Trials

Trial Activity

10 trials

Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

Recruiting·UUniversity of Illinois at Chicago·Phase 2·NCT06919081·24 enrolled

Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases

Not yet recruiting·—·Phase 2·NCT07382453·30 enrolled

Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

Completed·UUniversity of Illinois at Chicago·Phase 1·NCT05204329·9 enrolled

Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost

Completed·—·Phase 4·NCT04743622·57 enrolled

Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease

Completed·—·Phase 4·NCT03686059·90 enrolled

Impact of Prematurity on the Morphological and Tomographic Aspect of the Papilla

Completed·NNantes University Hospital·N/A·NCT04067973·88 enrolled

The Application of Fibrin Glue in Ocular Surface Diseases

Withdrawn·NNational Taiwan University Hospital·Phase 1·NCT00155402·30 enrolled

Evaluation of Dextenza in Patients With Ocular GVHD and Effects on Ocular Surface Disease Outcomes

Withdrawn·MMassachusetts Eye and Ear Infirmary·Phase 4·NCT04728646

Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease

Unknown status·UUniversity Health Network, Toronto·Phase 4·NCT04608084·100 enrolled

Transplantation of Cultivated Corneal Epithelial Sheet in Patients With Ocular Surface Disease

Unknown status·Ministry of Health, Malaysia·Phase 3·NCT01123044·42 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)